Retispec’s eye test tool could catch Alzheimer’s signs years earlier

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Check out how Retispec’s AI platform can detect early signs of Alzheimer’s from a simple eye exam in this article featured in the MaRS newsletter. Retispec’s innovative technology can transform Alzheimer’s disease screening by making it easily accessible and timely.

Retispec is an OBIO® member, an alumnus of the BDSP™, CAAP®, H2BB™, HealthMINT™ and WiHI programs and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Hypercare helps cut pagers and paper on-call schedules at Southlake thanks to OBIO®
Next

HDAX Therapeutics’ co-founder announced winner of 2023 Gold Leaf Awards for Next Generation Leadership